PF-04979064

AdipoGen Life Sciences
Product Code: SYN-1194
CodeSizePrice
SYN-1194-M100100 mgEnquire
Quantity:
SYN-1194-M05050 mgEnquire
Quantity:
SYN-1194-M0011 mg£238.00
Quantity:
SYN-1194-M0055 mg£461.00
Quantity:
SYN-1194-M01010 mg£719.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
4°C

Images

1 / 1
Chemical Structure

Chemical Structure

Further Information

Alternate Names/Synonyms:
PF04979064
Appearance:
Solid.
CAS:
1220699-06-8
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C24H26N6O3/c1-14-4-5-16(12-25-14)18-6-7-19-21(27-18)22-20(13-26-19)28(3)24(33)30(22)17-8-10-29(11-9-17)23(32)15(2)31/h4-7,12-13,15,17,31H,8-11H2,1-3H3/t15-/m0/s1
InChiKey:
GACQNUHFDBEIQH-HNNXBMFYSA-N
Long Description:
Chemical. CAS: 1220699-06-8. Formula: C24H26N6O3. MW: 446.5. PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) of 9.1nM for the PI3K family when tested AKT phosphorylation in BT20 cells. In direct kinase assays, PF-04979064 has potent Ki values against PI3Kalpha (Ki= 0.13nM human, 0.299nM mouse) and PI3Kgamma (Ki=0.111nM), and PI3Kdelta (Ki=0.122nM). In contrast, Ki values for non-PI3K kinases such as mTOR were 10X higher at 1.42 nM.
Molecular Formula:
C24H26N6O3
Molecular Weight:
446.5
Package Type:
Plastic Vial
Product Description:
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) of 9.1nM for the PI3K family when tested AKT phosphorylation in BT20 cells. In direct kinase assays, PF-04979064 has potent Ki values against PI3Kalpha (Ki= 0.13nM human, 0.299nM mouse) and PI3Kgamma (Ki=0.111nM), and PI3Kdelta (Ki=0.122nM). In contrast, Ki values for non-PI3K kinases such as mTOR were 10X higher at 1.42 nM.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 1 year after receipt when stored at +4°C.

References

Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design: H. Cheng, et al.; ACS Med. Chem. Lett. 4, 91 (2012)

Related Products

Product NameProduct CodeSupplier 
LY-294002AG-CR1-0108AdipoGen Life Sciences Summary Details